Co-Authors
This is a "connection" page, showing publications co-authored by JULIE NANGIA and VALENTINA HOYOS.
Connection Strength
0.401
-
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer. Ther Adv Med Oncol. 2022; 14:17588359221107113.
Score: 0.213
-
Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases. Curr Probl Cancer Case Rep. 2020 Dec 15; 2.
Score: 0.188